Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Peregrine Pharmaceuticals Inc (NASDAQ:PPHM)

Tuesday’s trading has closed, but PPHM is being traded in the after-hours session. After-Hours quote »
1.15
Delayed Data
As of 3:59pm ET
 0.00 / 0.00%
Today’s Change
1.00
Today|||52-Week Range
1.75
-17.27%
Year-to-Date

Today’s Trading

Previous close1.15
Today’s open1.14
Day’s range1.14 - 1.18
Volume1,234,086
Average volume (3 months)1,124,034
Market cap$231.6M
Dividend yield--
Data as of 3:59pm ET, 09/01/2015

Growth & Valuation

Earnings growth (last year)-36.36%
Earnings growth (this year)-3.33%
Earnings growth (next 5 years)--
Revenue growth (last year)+19.55%
P/E ratioNM
Price/Sales8.93
Price/Book3.77

Competitors

 Today’s
change
Today’s
% change
--China Health Group I...-0.01-2.00%
ASMBAssembly Biosciences...-0.09-0.66%
DRNADicerna Pharmaceutic...-0.37-3.37%
NVLSNivalis Therapeutics...-0.12-0.83%
Data as of 3:59pm ET, 09/01/2015

Financials

Next reporting dateSeptember 7, 2015
EPS forecast (this quarter)-$0.08
Annual revenue (last year)$26.8M
Annual profit (last year)-$50.4M
Net profit margin-188.04%

Profile

Sector
Health Technology
Industry
Medical Specialties
President, Chief Executive Officer &
Director
Steven W. King
CFO &
Principal Accounting Officer
Paul J. Lytle
Corporate headquarters
Tustin, California

Forecasts

Partner Offers